The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dynamic cell free HPV DNA is an early measure of treatment responsiveness in patients receiving induction chemotherapy for HPV-related head and neck cancer.
 
Linda (Yilin) Cao
No Relationships to Disclose
 
Ana Ponce Kiess
Research Funding - Bayer; Merck; Novartis
 
Michael Hwang
No Relationships to Disclose
 
Karim Boudadi
No Relationships to Disclose
 
Vassiliki Saloura
No Relationships to Disclose
 
Austin Mattox
No Relationships to Disclose
 
Emily Gramiccioni
Employment - Sysmex
Research Funding - Sysmex
Travel, Accommodations, Expenses - Sysmex
Other Relationship - Sysmex
 
David Schmitt
Employment - Sysmex
Research Funding - Sysmex
Travel, Accommodations, Expenses - Sysmex
Other Relationship - Sysmex
 
Jennifer Preston
Employment - Sysmex
Research Funding - Sysmex
Travel, Accommodations, Expenses - Sysmex
Other Relationship - Sysmex
 
Anna Malgorzata Starus
Employment - Sysmex
Research Funding - Sysmex
Travel, Accommodations, Expenses - Sysmex
Other Relationship - Sysmex
 
Frederick S. Jones
Employment - Sysmex
Research Funding - Sysmex
Travel, Accommodations, Expenses - Sysmex
Other Relationship - Sysmex
 
Tanguy Y. Seiwert
Honoraria - Merck; Nanobiotix
Consulting or Advisory Role - BostonGene; Innate Pharma; Merck; Nanobiotix; Regeneron; VIR Biotechnology
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Merck; Nanobiotix
 
Harry Quon
Employment - Pistevo Decision
Leadership - Pistevo Decision
Stock and Other Ownership Interests - Pistevo Decision